HUTCHMED (China) Limited News

Latest updates and market news for HCM

1 news

Mar 23 - Mar 29, 2026

Page 1

$HUTCHMED Initiates Phase III Trial of HMPL-760 in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma in China$

GlobeNewswire

7 days ago

📈

AI Sentiment

Highly Positive

9/10

Share this news page